Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Two-Dose H1N1 Vaccination Might Be Optimal, But Would Stress Supply

Executive Summary

An FDA panel said the H1N1 flu vaccine should be given in two doses when the probable vaccine campaign starts in the fall, but government officials at the meeting said there will not likely be enough vaccine available at that point to follow that advice

You may also be interested in...



H1N1 Vaccination Campaign Will Build Active Surveillance System To Monitor Guillian-Barres Syndrome

Multi-faceted effort includes text messages to vaccinees, a grant for Johns Hopkins, and extra funding for 10 state health departments.

H1N1 Vaccine Makers Get New Virus Strains In Hopes Of Increasing Yield

Adequate supply of the vaccine is key to FDA's determination of whether to approve adjuvanted H1N1 vaccines.

H1N1 Vaccine Trials: NIH Will Mix And Match Antigens, Adjuvants

The National Institutes of Health is developing a plan B as H1N1 vaccine manufacturers race to produce enough product by the start of flu season. The agency is going to mix and match antigen and adjuvant from different sponsors to try to find the best immunogenicity

Related Content

Topics

UsernamePublicRestriction

Register

OM001644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel